Stock listing
CTOR Stock Price, News, Filings & Events — Citius Oncology, Inc.
Selected listing: CTOR · NASDAQ · USD · US
CTOR:NASDAQ is the public listing for Citius Oncology, Inc., a company dedicated to developing innovative cancer therapies. With a market capitalization of around $64 million, Citius is focused on advancing treatments that aim to enhance patient outcomes in oncology. The company is currently engaged in research and development efforts to introduce new solutions to the market. Recent news and filings highlight its commitment to addressing unmet needs in cancer care.
- Ticker
- CTOR:NASDAQ
- Asset type
- Stock
- Market cap
- $64.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Citius Oncology, Inc. CTOR:NASDAQ stock context
CTOR:NASDAQ is the public listing for Citius Oncology, Inc., a company dedicated to developing innovative cancer therapies. With a market capitalization of around $64 million, Citius is focused on advancing treatments that aim to enhance patient outcomes in oncology. The company is currently engaged in research and development efforts to introduce new solutions to the market. Recent news and filings highlight its commitment to addressing unmet needs in cancer care.
Research Citius Oncology, Inc.
Citius Oncology, Inc. investor report
Review AI stock analysis and investor report context for CTOR:NASDAQ.
Citius Oncology, Inc. company profile
View the public company page for Citius Oncology, Inc. on 6ix.
Citius Oncology, Inc. news
Read company news and market updates connected to Citius Oncology, Inc..
Citius Oncology, Inc. investor events
Find investor webinars, events, and replay context for Citius Oncology, Inc..